Agape ATP PE Ratio 2021-2025 | ATPC
Current and historical p/e ratio for Agape ATP (ATPC) from 2021 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Agape ATP PE ratio as of August 08, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Agape ATP PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-08 | 1.37 | 0.00 | |
| 2025-03-31 | 1.28 | $-0.60 | 0.00 |
| 2024-12-31 | 1.18 | $-0.73 | 0.00 |
| 2024-09-30 | 1.95 | $-0.73 | 0.00 |
| 2024-06-30 | 4.24 | $-0.60 | 0.00 |
| 2024-03-31 | 6.60 | $-0.60 | 0.00 |
| 2023-12-31 | 12.78 | $-0.40 | 0.00 |
| 2023-09-30 | 140.00 | $-0.20 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.067B | $0.001B |
| AGAPE ATP CORPORATION is primarily operating in ASEAN region which supplies wellness products and health solution advisory services, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body. AGAPE ATP CORPORATION is based in KUALA LUMPUR, MALAYSIA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.845B | 26.95 |
| Boston Scientific (BSX) | United States | $152.561B | 36.38 |
| Stryker (SYK) | United States | $143.889B | 29.29 |
| EssilorLuxottica (ESLOY) | France | $136.285B | 0.00 |
| Medtronic (MDT) | Ireland | $116.952B | 16.59 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.016B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.497B | 24.26 |
| ResMed (RMD) | United States | $41.081B | 29.34 |
| GE HealthCare Technologies (GEHC) | United States | $32.462B | 15.26 |
| Agilent Technologies (A) | United States | $32.378B | 21.11 |
| Terumo (TRUMY) | Japan | $27.642B | 32.75 |
| Koninklijke Philips (PHG) | Netherlands | $25.623B | 16.95 |
| Insulet (PODD) | United States | $21.362B | 71.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.474B | 12.41 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.802B | 0.00 |
| Baxter (BAX) | United States | $12.091B | 9.34 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.599B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.179B | 26.37 |
| Lantheus Holdings (LNTH) | United States | $3.730B | 10.09 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.341B | 14.76 |
| Envista Holdings (NVST) | United States | $3.339B | 23.36 |
| ICU Medical (ICUI) | United States | $3.197B | 21.83 |
| Perrigo (PRGO) | Ireland | $3.141B | 7.85 |
| Haemonetics (HAE) | United States | $2.673B | 11.96 |
| LeMaitre Vascular (LMAT) | United States | $2.134B | 45.76 |
| AtriCure (ATRC) | United States | $1.784B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.657B | 10.43 |
| Green Thumb Industries (GTBIF) | United States | $1.478B | 63.46 |
| AdaptHealth (AHCO) | United States | $1.252B | 17.85 |
| Curaleaf Holdings (CURLF) | Canada | $1.200B | 0.00 |
| Acuren (TIC) | United States | $1.180B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.108B | 14.16 |
| Neogen (NEOG) | United States | $1.086B | 17.24 |
| BioLife Solutions (BLFS) | United States | $0.987B | 2064.00 |
| InMode (INMD) | Israel | $0.908B | 8.40 |
| Kestra Medical Technologies (KMTS) | United States | $0.757B | 0.00 |
| Valneva SE (VALN) | France | $0.702B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.655B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.516B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.487B | 4.04 |
| CeriBell (CBLL) | United States | $0.461B | 0.00 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Evolus (EOLS) | United States | $0.393B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.369B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.322B | 11.16 |
| Verano Holdings (VRNOF) | United States | $0.307B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.294B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.270B | 20.47 |
| Cerus (CERS) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.237B | 0.00 |
| Omeros (OMER) | United States | $0.233B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.15 |
| Sanara MedTech (SMTI) | United States | $0.217B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.201B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.200B | 0.00 |
| Exagen (XGN) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.89 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Biote (BTMD) | United States | $0.160B | 4.79 |
| TerrAscend (TSNDF) | Canada | $0.156B | 0.00 |
| Safety Shot (SHOT) | United States | $0.139B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 16.81 |
| Jushi Holdings (JUSHF) | United States | $0.124B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.63 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| Veru (VERU) | United States | $0.055B | 0.00 |
| Zynex (ZYXI) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 12.60 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 24.08 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |